Dalton Expands Cannabinoids Capabilities

02:55 EST 15 Jan 2020 | Contract Pharma

Receives license amendment from Health Canada Cannabis Regulation approving sale of cGMP cannabis derived products to License Holders.

Original Article: Dalton Expands Cannabinoids Capabilities


More From BioPortfolio on "Dalton Expands Cannabinoids Capabilities"

Quick Search

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...